Skip to main content
Top
Published in: Sleep and Breathing 4/2008

01-11-2008 | Original Article

CPAP compliance in patients with obstructive sleep apnea syndrome

Authors: Ozkan Yetkin, Erdogan Kunter, Hakan Gunen

Published in: Sleep and Breathing | Issue 4/2008

Login to get access

Abstract

Obstructive sleep apnea syndrome (OSAS) is characterized by repeated cessations of breathing during sleep. Major symptoms of this disease are excessive daytime sleepiness, snoring, and witnessed apnea. Most of the patients are treated with CPAP. In this study, we aimed to evaluate the factors affecting adherence to the CPAP treatment. Seventy-one patients were enrolled to this study. Patients were divided into three groups according to CPAP usage. Group I consisted of patients who had never used CPAP, group II consisted of patients who had used CPAP occasionally, and group-III patients had used CPAP treatment regularly. Group-III patients had higher apnea–hypopnea index (AHI) than groups I and II (respectively, 56.6 ± 27.7, 26.3 ± 7.5, and 32.3 ± 7.06; p < 0.000 for both). Oxygen desaturation index was significantly higher in group-III patients comparing to groups I and II (44.6 ± 22.3, 15.9 ± 8.3, and 25.6 ± 9.5; p < 0.000 for all). Our findings have shown that only very severe patients use the CPAP device regularly (mean AHI 56.6 ± 27.7). Compliance to CPAP treatment seemed to be poor in patients with moderate to severe, AHI about 30, OSAS. Considering the well-established benefits of CPAP treatment in patients with true indications, patients should be encouraged to use CPAP regularly, and complications of OSAS should be keynoted.
Literature
1.
go back to reference Sanders MH (2005) Sleep breating disorders. In: Kryger MH, Roth T, Dement WC (eds) Principles and practice of sleep medicine. 4th edn. Elsevier, Amsterdam, pp 969–1121 Sanders MH (2005) Sleep breating disorders. In: Kryger MH, Roth T, Dement WC (eds) Principles and practice of sleep medicine. 4th edn. Elsevier, Amsterdam, pp 969–1121
3.
go back to reference He J, Kryger MH, Zorick FJ, Conway W, Roth T (1988) Mortality and apnea index in obstructive sleep apnea: experience in 385 male patients. Chest 94:9–14PubMedCrossRef He J, Kryger MH, Zorick FJ, Conway W, Roth T (1988) Mortality and apnea index in obstructive sleep apnea: experience in 385 male patients. Chest 94:9–14PubMedCrossRef
4.
go back to reference Kakkar RK, Berry RB (2007) Positive airway pressure treatment for obstructive sleep apnea. Chest 132:1057–1072PubMedCrossRef Kakkar RK, Berry RB (2007) Positive airway pressure treatment for obstructive sleep apnea. Chest 132:1057–1072PubMedCrossRef
5.
go back to reference Janson C, Noges E, Svedberg-Brandt S, Lindberg E (2000) What characterizes patients who are unable to tolerate continuous positive airway pressure (CPAP) treatment. Respir Med 94:145–149PubMedCrossRef Janson C, Noges E, Svedberg-Brandt S, Lindberg E (2000) What characterizes patients who are unable to tolerate continuous positive airway pressure (CPAP) treatment. Respir Med 94:145–149PubMedCrossRef
6.
go back to reference Johns MW (1991) A new method for measuring daytime sleepiness. Sleep 14:540–545PubMed Johns MW (1991) A new method for measuring daytime sleepiness. Sleep 14:540–545PubMed
7.
go back to reference American Academy Of Sleep Medicine (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine task force. Sleep 22:667–689 American Academy Of Sleep Medicine (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine task force. Sleep 22:667–689
8.
go back to reference Hoffstein V (2007) Review of oral appliances for treatment of sleep-disordered breathing. Sleep Breath 11:1–22PubMedCrossRef Hoffstein V (2007) Review of oral appliances for treatment of sleep-disordered breathing. Sleep Breath 11:1–22PubMedCrossRef
9.
go back to reference Prinsell JR (2002) Maxillomandibular advancement surgery for obstructive sleep apnea syndrome. J Am Dent Assoc 133:1489–1497PubMed Prinsell JR (2002) Maxillomandibular advancement surgery for obstructive sleep apnea syndrome. J Am Dent Assoc 133:1489–1497PubMed
10.
go back to reference American Thoracic Society Official Statement (1994) Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndrome. Am J Respir Crit Care Med 150:1738–1745 American Thoracic Society Official Statement (1994) Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndrome. Am J Respir Crit Care Med 150:1738–1745
11.
go back to reference Polo O, Berthon-Jones M, Douglas NJ, Sullivan CE (1994) Management of obstructive sleep apnoea/hypopnoea syndrome. Lancet 344:656–660PubMedCrossRef Polo O, Berthon-Jones M, Douglas NJ, Sullivan CE (1994) Management of obstructive sleep apnoea/hypopnoea syndrome. Lancet 344:656–660PubMedCrossRef
12.
go back to reference Kawahara S, Akashiba T, Akahoshi T, Horie T (2005) Nasal CPAP improves the quality of life and lessens the depressive symptoms in patients with obstructive sleep apnea syndrome. Intern Med 44:422–427PubMedCrossRef Kawahara S, Akashiba T, Akahoshi T, Horie T (2005) Nasal CPAP improves the quality of life and lessens the depressive symptoms in patients with obstructive sleep apnea syndrome. Intern Med 44:422–427PubMedCrossRef
13.
go back to reference Fidan F, Unlu M, Sezer M, Gecici O, Kara Z (2007) Compliance to CPAP treatment and effects of treatment on anxiety and depression in patients with obstructive sleep apnea syndrome. Tuberk Toraks 55:271–277PubMed Fidan F, Unlu M, Sezer M, Gecici O, Kara Z (2007) Compliance to CPAP treatment and effects of treatment on anxiety and depression in patients with obstructive sleep apnea syndrome. Tuberk Toraks 55:271–277PubMed
Metadata
Title
CPAP compliance in patients with obstructive sleep apnea syndrome
Authors
Ozkan Yetkin
Erdogan Kunter
Hakan Gunen
Publication date
01-11-2008
Publisher
Springer-Verlag
Published in
Sleep and Breathing / Issue 4/2008
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-008-0188-4

Other articles of this Issue 4/2008

Sleep and Breathing 4/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.